About Mecasermin
            
            Class: | Recombinant Insulin-like Growth Factor-1 (IGF-1)  
Use: | Treatment of growth failure in children with severe primary IGF-1 deficiency or with growth hormone gene deletion who have developed neutralizing antibodies to growth hormone  
Adult dose: | Not indicated for adults  
Pediatric dose: | Initial dose of 0.04 to 0.1 mg/kg subcutaneously once daily, may be increased based on response and tolerability, up to a maximum of 0.12 mg/kg  
Side effects: | Hypoglycemia, injection site reacti
         
        
            
                
                
                    
                        Drug Class
                    
                    Recombinant Insulin-like Growth Factor-1 (IGF-1)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of growth failure in children with severe primary IGF-1 deficiency or with growth hormone gene deletion who have developed neutralizing antibodies to growth hormone
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator (2°C to 8°C); do not freeze; may be kept at room temperature (up to 25°C) for up to 30 days after opening
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Tercica Inc., U.S.A
                    
                    
                    Package Size
                    4ml Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 2703.48
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Not indicated for adults
                    
                    
                        Pediatric Dose
                    
                    
                        Initial dose of 0.04 to 0.1 mg/kg subcutaneously once daily, may be increased based on response and tolerability, up to a maximum of 0.12 mg/kg
                    
                 
                
                
                    
                        Side Effects
                    
                    Hypoglycemia, injection site reactions, headache, nausea, vomiting, and tonsillar hypertrophy
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to mecasermin or any component of the formulation; neoplasia; closed epiphyses; severe hypoglycemia
         
        
        
            
                Important Warnings
            
            Monitor for hypoglycemia; patients should be educated on signs and symptoms; may cause an increase in intracranial pressure; use with caution in patients with a history of malignancy or those with a risk of malignancy
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.